{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:34:24Z","timestamp":1790242464628,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,5]],"date-time":"2004-07-05T00:00:00Z","timestamp":1088985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p><jats:bold>Abstract: \u2028Background: <\/jats:bold> Hepatocyte growth factor (HGF) is a potent mitogen for hepatocytes <jats:italic>in vitro<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Aims: <\/jats:bold> Substitution of HGF was suggested for human liver disease on the basis of animal experiments. The cellular sources of HGF and its receptor, c\u2010Met, in liver disease <jats:italic>in vivo<\/jats:italic> are not well defined.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> We characterised HGF and c\u2010Met expression in normal and cirrhotic human livers and rat livers at various time points after CCl<jats:sub>4<\/jats:sub> administration by <jats:italic>in situ<\/jats:italic> hybridisation and immunohistology. HGF transcripts were restricted to resting and activated stellate cells in rat and human liver.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> In rat liver, HGF showed peak levels 6\u201312\u2003h following acute intoxication, and remained increased after repeated CCl<jats:sub>4<\/jats:sub> injury. HGF transcript levels were very low in normal human liver, but excessively raised in fibrosis\/cirrhosis. In contrast, HGF immunoreactivity was found not only in perisinusoidal\/periductular cells but also in cholangiocytes of proliferating ductules. c\u2010Met RNA and protein was expressed in hepatocytes, cholangiocytes, and arteriolar endothelial cells.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> The HGF\u2010specific immunostaining of proliferating cholangioles in the absence of HGF RNA suggests c\u2010Met\u2010mediated uptake of HGF and paracrine stimulation of cholangiocellular proliferation. Mitogenic effects of HGF on hepatocytes may therefore be accompanied by undesired cholangiogenesis and angiogenesis limiting its therapeutic value in chronic liver disease.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2004.0926.x","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T12:56:46Z","timestamp":1091192206000},"page":"335-344","source":"Crossref","is-referenced-by-count":28,"title":["Hepatocyte growth factor and c\u2010Met expression in rat and human liver fibrosis"],"prefix":"10.1111","volume":"24","author":[{"given":"Thorsten","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pfander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,5]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2247"},{"key":"e_1_2_7_3_2","first-page":"2244","article-title":"Cell\u2010specific expression of hepatocyte growth factor in liver","volume":"91","author":"Maher J J.","year":"1993","journal-title":"upregulation in sinusoidal endothelial cells after carbon tetrachloride"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7001"},{"key":"e_1_2_7_5_2","first-page":"501","article-title":"Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto\u2010oncogene c\u2010MET","volume":"6","author":"Naldini L","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_7_6_2","first-page":"3256","article-title":"Expression of neoplasia\u2010related proteins of chemically transformed HuT fibroblasts in human osteosarcoma HOS fibroblasts and modulation of actin expression upon elevation of tumorigenic potential","volume":"45","author":"Goldstein D","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1242\/jcs.108.12.3703","article-title":"The hepatocyte growth factor\/scatter factor (HGF\/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells","volume":"108","author":"Kolatsi\u2010Joannou M","year":"1995","journal-title":"J Cell Sci"},{"key":"e_1_2_7_8_2","first-page":"2897","article-title":"HGF\/SF","volume":"121","author":"Niranjan B","year":"1995","journal-title":"a potent cytokine for mammary growth, morphogenesis and development"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150125"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150103"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81018-6"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.1840190513","article-title":"Ultrastructural location of human hepatocyte growth factor in human liver","volume":"19","author":"Sakaguchi H","journal-title":"Hepatology"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90545-V"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1210\/endo.131.6.1446596","article-title":"Reduction of alpha\u2010naphthylisothiocyanate\u2010induced hepatotoxicity by recombinant human hepatocyte growth factor","volume":"131","author":"Roos F","year":"1992","journal-title":"Endocrinology"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00744-8"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260111"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240328"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260523"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/5593"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004180050126"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/342440a0"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.18.6379"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70642-0"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92733-2"},{"key":"e_1_2_7_25_2","first-page":"35","article-title":"Clinical significance of serum hepatocyte growth factor levels in liver diseases","volume":"24","author":"Hioki O","year":"1993","journal-title":"J Med"},{"key":"e_1_2_7_26_2","first-page":"227","article-title":"Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo","volume":"47","author":"Rosen E M","year":"1993","journal-title":"Symp Soc Exp Biol"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)91548-5"},{"key":"e_1_2_7_28_2","first-page":"5775","article-title":"Coexpression of the c\u2010met proto\u2010oncogene and hepatocyte growth factor in human pancreatic cancer","volume":"54","author":"Ebert M","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_7_29_2","first-page":"2549","article-title":"Overexpression of the c\u2010MET\/HGF receptor gene in human thyroid carcinomas","volume":"7","author":"Di Renzo M F","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215549704500111"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115992"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240532"},{"key":"e_1_2_7_33_2","first-page":"1221","article-title":"Transforming growth factors \u03b21 and \u03b22 are differentially expressed in chronic liver disease","volume":"139","author":"Milani S","year":"1991","journal-title":"Am J Pathol"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64074-6"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80169-X"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2004.0926.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2004.0926.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:21:17Z","timestamp":1697300477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2004.0926.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,5]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1478-3231.2004.0926.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2004.0926.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,5]]}}}